Partner Investment Management’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $37K | Sell |
153
-13
| -8% | -$3.14K | 0.27% | 40 |
|
|
2019
Q3 | $57K | Buy |
+166
| New | +$57K | 0.1% | 61 |
|
|
2019
Q1 | – | Sell |
-109
| Closed | -$204K | – | 112 |
|
|
2018
Q4 | $204K | Sell |
109
-20
| -16% | -$37.4K | 0.25% | 64 |
|
|
2018
Q3 | $305K | Sell |
129
-102
| -44% | -$241K | 0.23% | 81 |
|
|
2018
Q2 | $795K | Sell |
231
-155
| -40% | -$533K | 0.64% | 57 |
|
|
2018
Q1 | $1.1M | Sell |
386
-59
| -13% | -$168K | 1.18% | 35 |
|
|
2017
Q4 | $1.15M | Sell |
445
-54
| -11% | -$139K | 1.32% | 32 |
|
|
2017
Q3 | $1.42M | Buy |
499
+101
| +25% | +$287K | 1.34% | 24 |
|
|
2017
Q2 | $941K | Buy |
+398
| New | +$941K | 1.26% | 28 |
|
|
2016
Q2 | – | Sell |
-93
| Closed | -$296K | – | 97 |
|
|
2016
Q1 | $296K | Sell |
93
-140
| -60% | -$446K | 0.48% | 49 |
|
|
2015
Q4 | $1.2M | Buy |
233
+49
| +27% | +$251K | 1.96% | 21 |
|
|
2015
Q3 | $587K | Buy |
184
+22
| +14% | +$70.2K | 0.89% | 40 |
|
|
2015
Q2 | $650K | Buy |
162
+65
| +67% | +$261K | 0.91% | 44 |
|
|
2015
Q1 | $386K | Sell |
97
-163
| -63% | -$649K | 0.58% | 60 |
|
|
2014
Q4 | $1.27M | Buy |
260
+26
| +11% | +$127K | 0.52% | 47 |
|
|
2014
Q3 | $950K | Buy |
+234
| New | +$950K | 0.35% | 34 |
|
|
2014
Q2 | – | Sell |
-237
| Closed | -$1.08M | – | 82 |
|
|
2014
Q1 | $1.08M | Buy |
+237
| New | +$1.08M | 0.2% | 51 |
|